Talis Capital is a London-based venture capital firm investing in early-stage companies across the UK, Europe and the US.
Portfolio
11
companies
BondAval
BondAval offers a new form of payment security for supply chains.
IMMO
Residential real estate investment platform streamlining property acquisition for institutional investors.
IMMO Investment Technologies
IMMO Investment Technologies digitises the sourcing and acquisition of residential real estate for institutional investors.
Insurdata
Insurdata supplies granular risk data and exposure analytics to the insurance industry.
Laced
Laced operates an authenticated digital marketplace for rare sneakers and luxury fashion.
Medbelle
Medbelle provides a digital platform for medical procedures and patient care coordination.
Onfido
Onfido provides digital identity verification and authentication through artificial intelligence.
Plum Guide
Plum Guide curates a selective collection of holiday homes by vetting properties for quality and design.
The Plum Guide
The Plum Guide curates and verifies top-tier holiday rentals for discerning travellers.
Vinehealth
Vinehealth provides a digital platform that supports cancer patients and collects clinical outcome data.
eporta
A B2B platform connecting trade buyers directly with global furniture manufacturers.
Matus Maar
Managing Partner and Co Founder
Matus is founder and CEO of choosenul.com and co-founder and managing partner at Talis Capital. He previously led investments in companies including Onfido and Luminance.
LinkedInTom Williams
Principal
Tom serves as a general partner at Talis Capital, where he previously held the role of principal. He also co-founded KOYO and maintains board positions at Bondaval and StockStory.
LinkedInVasile Foca
Managing Partner
Vasile co-founded Talis Capital, where he serves as managing partner, alongside holding founding and directorship roles across several investment and portfolio companies.
LinkedInBeatrice Aliprandi
Principal
Beatrice is a principal at Talis Capital, having previously held the same title at Lakestar. She also co-hosts Top of the Ops and serves as chief of staff at Praktika.
LinkedIn
Thomas Williams
General Partner
Thomas is a general partner at Elder Gull and Talis Capital, alongside founding KOYO and holding board positions at Bondaval, Perceptic, and Mimira.
LinkedInKirill Tasilov
General Partner
The investment round was led by Talis Capital with participation from H&M Group Ventures and existing backers.
"At Talis, we partner with founders who are set to redefine their industries with unconventional thinking, and Laced embodies this. We saw the business’ potential from the very beginning and this funding round demonstrates our continued support in becoming the leading marketplace for sought-after sneakers and high end luxury fashion."
The Series A round was led by Talis Capital to support team expansion and global growth.
"When we first established the business less than 2 years ago, we could only imagine how quickly the market would respond to our technology-led approach for payment security. We are honoured by the confidence shown by our existing investors and our new investors and the validation from our best in class clients. We look forward to increasing access to more favourable financial security for all parties involved in B2B credit transactions and demonstrating more applications for our MicroBonds."
Oak HC/FT led the Series B round to support European expansion and technology development.
"The moment has come to open up and professionalise the European residential market."
The investment was led by Beringea with participation from Talis Capital, Hearst Ventures, and Latitude.
"With British consumers spending more in 2022 than in previous years, there is no room for error and so we strive to set that global standard for quality in the travel sector that has previously been lacking. We are catering to discerning global travellers who simply expect the best; they want unique properties in exciting destinations for a homestay in comfort and style and this investment will allow us to scale up to meet that demand."
The financing round was led by Talis Capital with participation from multiple angels and existing backers.
"We are delighted to have received such credible investor support to continue on our mission to empower and support those with cancer. It’s imperative that we start understanding how therapies are affecting patients: for pharmaceutical companies, our technology enables deeper patient understanding which leads to better drugs, greater differentiation and faster licensing, as well as the ability to provide personalised scalable support to patients. For patients, this means better care and improved outcomes from cancer. We’re now looking forward to applying our rich data and machine learning capabilities to novel predictive analytics to generate even richer insights for our life science partners."
